Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. - Wikidata - awgldk - TriplyDB

Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.

Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.

http://www.wikidata.org/entity/Q53133020

about

Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography Hodgkin lymphoma, version 2.2015.PET/CT in Oncology: Current Status and Perspectives.Hodgkin disease-an ever-evolving therapy.Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Positron Emission Tomography (PET) in Oncology The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase.FDG-PET imaging in hematological malignancies The Impact of 2-(18) Fluoro-2-Deoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Treatment Strategy of Hodgkin Lymphoma-Current Hematologic Concepts.PET/CT in malignant lymphoma: basic information, clinical application, and proposal.When should FDG-PET be used in the modern management of lymphoma?Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?Current role of FDG PET/CT in lymphoma.Role of PET in lymphoma.Management and controversies of classical Hodgkin lymphoma in pregnancy.PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement.Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.Pathogenesis and FDG-PET/CT findings of Epstein-Barr virus-related lymphoid neoplasms.Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.Dealing with bone marrow biopsies in the staging of classical Hodgkin lymphoma: an old issue revisited in the (18)F-fluorodeoxyglucose-positron emission tomography era.The role of FDG-PET in Hodgkin lymphoma Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012.Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study.The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvement.Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.Hodgkin lymphoma: A review and update on recent progress.International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).RETRACTED ARTICLE: The diagnostic performance of 18F-FDG PET in detecting bone marrow infiltration in Hodgkin's lymphoma and diffuse large B-cell lymphoma: a meta-analysis.Report on the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.

P2860

Q26801870-2F1A991A-0AB5-481C-AB25-678D9547D675 Q30769157-C1E33A3C-7F58-4060-954D-815D0EC118FC Q33665109-314D9DA5-8805-435D-A4E5-2B22993F6C61 Q34463426-64166478-E300-4415-8C33-8D8DBC5EE56A Q34663865-5A907DD6-815E-4E80-A710-499B41BA41F0 Q34664223-BEB8A687-62DD-4904-8EEE-768E93BAD477 Q34774840-326CE0D5-6756-45FD-9538-81031A9D8B71 Q36663969-597B350E-81FE-40F4-844A-F82AD2A76BCA Q37109937-FB4FB410-54F4-4FA8-81E8-88C9DD198453 Q37144956-61E18A7A-D9A8-4682-9768-C35CBE3F3216 Q37240835-6AA602CB-9673-4F23-9CF3-A50CD4A46C1F Q37602246-E91E54F1-C2CC-4F4A-B112-75A1F024ADD1 Q37632114-3A815DB4-86CB-45E1-A607-64E8E42DFC3E Q37668943-673E4490-F59B-48F2-B59E-2768990CEA91 Q38142869-C9E7C4B4-5A96-4508-AD2B-237ADBA42348 Q38153086-9B144059-5129-4602-8EF8-0E9B9603FD7F Q38172327-08CF3377-FD66-42CC-ACDD-79BBA943E9F2 Q38187365-B0A2938C-A1A1-4C30-866A-9796C390DFA4 Q38195220-E8A6FD2A-D350-4BF6-800D-2B873E44386A Q38356460-81D6C307-7EA0-46AA-9BCA-8530EC755FE2 Q38794783-98AE6D71-D654-4352-A939-47DE802A63D9 Q38815516-5C5A6FC5-D19F-4484-B298-8401ED2A5705 Q38831143-DEA3229D-6E1B-457D-A269-228A7EB6CB59 Q38878481-7F7E763A-EFDA-4990-AB7B-88F4E2381EA6 Q38947173-5A3B3B7D-2621-4538-A6B2-F877AF9A7D5C Q38948399-0452E277-851D-4256-990E-A57A387BCD8B Q39301790-7DFC2083-2C15-4A94-87D7-C9235E666DC7 Q40015245-1588BD4C-DB62-479C-BDF7-1069BB9E5DEC Q40616101-99F2C320-9E77-4893-BC71-5A93DF577403 Q41387425-446D916F-B69F-4918-A067-F92EAD72C961 Q41691698-61C05869-B90A-4878-ADFB-46A64032CA5C Q42603371-CD54FE5C-8F9D-4703-9924-DACD02A64F85 Q43507515-ED7CA6F3-972D-45F0-8CB3-7FF8121797E0 Q44225679-ACAF15EF-3034-4D3A-84DE-C94140446871 Q44624532-CD56F194-055D-4846-A3B4-79B66A817D12 Q46605997-A7104B73-4530-456F-A94C-FC6D6CE9AC0E Q47807176-61DAFA4D-B7D2-43A3-AAA4-499FB119B214 Q48669191-79347250-B7C1-473A-B6AB-6535E99F18D9 Q48829538-E589B5A3-001E-45F2-B2A9-FA92DB610569 Q49027912-3A5B6D9C-1327-4A09-B511-BF7C3A959E24

P2860

Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.

http://www.wikidata.org/entity/Q53133020

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Routine bone marrow biopsy has ...... atients with Hodgkin lymphoma.

@en

Routine bone marrow biopsy has ...... atients with Hodgkin lymphoma.

@nl

type

label

Routine bone marrow biopsy has ...... atients with Hodgkin lymphoma.

@en

Routine bone marrow biopsy has ...... atients with Hodgkin lymphoma.

@nl

prefLabel

Routine bone marrow biopsy has ...... atients with Hodgkin lymphoma.

@en

Routine bone marrow biopsy has ...... atients with Hodgkin lymphoma.

@nl

P1433

Q53133020-C1A15E9D-E30C-4C07-B77E-560A6EAFD213

P1476

Q53133020-80EC4A59-730B-4B32-A28B-38AC27127F83

P2093

Q53133020-106267BD-4D95-4414-9FAF-AF27EEF9F715

Q53133020-23C2A29A-CE50-416D-A9E3-3A374B5E1FB6

Q53133020-2B399CB2-ADD5-4323-B151-51D7DF5C8737

Q53133020-4C9C0474-7540-4652-BEE4-26A80FF84036

Q53133020-50644EA3-DE5E-456F-98A9-21880C23971E

Q53133020-63730CA9-F6A4-40EE-AC4B-5C73F01BFCFA

Q53133020-6FB7BE89-0141-4C01-8FF5-CC23DCA864D1

Q53133020-CDFE2C8D-DEDB-4CCE-9867-11303AA9F5F5

Q53133020-DF17720D-5162-4765-AB52-67078BEC3D97

Q53133020-E67BCBAC-1A9F-4B5A-9541-7CAB53777B59

P304

Q53133020-2A7F9AA3-BFEE-4D45-9CCF-E5FD08EFB222

P31

Q53133020-92753295-A003-46E1-8444-1B71C711C44B

P356

Q53133020-0D08917B-192F-4900-8F6E-201F4EBD0D43

P407

Q53133020-7A47922F-8BBF-429B-9654-0D5C0E8BF3B8

P433

Q53133020-43DDB7C6-9BDD-460D-A9F3-A076D34DD2A8

P478

Q53133020-522196CE-FFC9-4555-AABC-C026D3D34D0C

P50

Q53133020-34DFAF5A-04F7-48EC-AB37-4A5D7324074A

Q53133020-610C9183-8B22-4F70-BCC4-5B371560907F

Q53133020-9249BAED-47EB-439E-B130-EEA186791C2B

Q53133020-97C687A9-1C16-4DF2-8554-C4F0CDFE5918

P577

Q53133020-D6856923-9B44-4020-8F49-D1665443A9BA

P698

Q53133020-89757996-489C-44E1-9FB7-8A2AD01EAB27

P356

JCO.2012.42.4036

P1433

Journal of Clinical Oncology

P1476

Routine bone marrow biopsy has ...... atients with Hodgkin lymphoma.

@en

P2093

Anne Bukh

http://www.w3.org/2001/XMLSchema#string

Anne Lerberg Nielsen

http://www.w3.org/2001/XMLSchema#string

Annika Loft

http://www.w3.org/2001/XMLSchema#string

Charlotte Madsen

http://www.w3.org/2001/XMLSchema#string

Francesco d'Amore

http://www.w3.org/2001/XMLSchema#string

Ilse Christiansen

http://www.w3.org/2001/XMLSchema#string

Karen Juul Mylam

http://www.w3.org/2001/XMLSchema#string

Karin Hjorthaug

http://www.w3.org/2001/XMLSchema#string

Martin Hutchings

http://www.w3.org/2001/XMLSchema#string

Peter de Nully Brown

http://www.w3.org/2001/XMLSchema#string

P304

4508-4514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2012.42.4036

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Martin Bøgsted

Tarec Christoffer El-Galaly

Hans Erik Johnsen

P577

2012-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23150698

http://www.w3.org/2001/XMLSchema#string